Decreased plasma levels of perfluoroalkylated substances one year after bariatric surgery.


Journal

The Science of the total environment
ISSN: 1879-1026
Titre abrégé: Sci Total Environ
Pays: Netherlands
ID NLM: 0330500

Informations de publication

Date de publication:
20 Mar 2019
Historique:
received: 01 10 2018
revised: 24 11 2018
accepted: 29 11 2018
entrez: 26 1 2019
pubmed: 27 1 2019
medline: 15 2 2019
Statut: ppublish

Résumé

Per- and polyfluoroalkylated substances (PFASs) are classified as persistent organic pollutants (POPs), and known to be protein bound. The aim of the present study was to determine the levels of 17 different PFASs before and one year after bariatric surgery, and to assess whether weight loss and changed serum protein concentrations could be influencing factors. Plasma samples from 63 patients were analyzed for nine perfluoroalkyl carboxylic acids (PFCAs), three perfluoroalkane sulfonic acids (PFSAs), and five perfluoroalkyl sulfonamide based substances (PASF) before and after surgery. Protein determination was performed in the corresponding serum samples. Mean weight loss one year after surgery was 32.1 kg. The plasma levels of all PFASs decreased with 4-34% compared to preoperative values, and included perfluorononanoic acid (PFNA), perfluorodecanoic acid (PFDA), perfluoroundecanoic acid (PFUnDA), and perfluorobutane sulfonate (PFBS), which have been identified with increasing levels in the general population during recent years. Serum protein concentrations also decreased with 7-8%. Although protein levels were positively correlated with PFOA, PFBS, PFHxS and PFOS, regression analysis revealed that neither weight loss nor reductions in concentrations of serum protein could explain the decreased PFAS levels. The type of surgical procedure did not influence the changes of PFAS levels between the two sample points. A reduced food intake and alterations in absorptions of nutrients after bariatric surgery may have influenced the observed decreasing plasma levels of PFASs.

Identifiants

pubmed: 30677951
pii: S0048-9697(18)34808-3
doi: 10.1016/j.scitotenv.2018.11.453
pii:
doi:

Substances chimiques

Carboxylic Acids 0
Decanoic Acids 0
Environmental Pollutants 0
Fluorocarbons 0
Sulfonic Acids 0
perfluorodecanoic acid 335-76-2
perfluorobutane SE4TWR0K2C

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

863-870

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Auteurs

Aina Jansen (A)

Department of Surgery, Innlandet Hospital Trust, Gjøvik, Norway; Department of Food Safety and Infection Biology, Norwegian University of Life Sciences (NMBU), Oslo, Norway. Electronic address: aina.jansen@sykehuset-innlandet.no.

Mette H B Müller (MHB)

Department of Food Safety and Infection Biology, Norwegian University of Life Sciences (NMBU), Oslo, Norway.

Randi Grønnestad (R)

Department of Food Safety and Infection Biology, Norwegian University of Life Sciences (NMBU), Oslo, Norway; Department of Biology, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.

Ole Klungsøyr (O)

Oslo Centre for Biostatistics and Epidemiology, Section for Treatment Research, Department for Research and Education, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.

Anuschka Polder (A)

Department of Food Safety and Infection Biology, Norwegian University of Life Sciences (NMBU), Oslo, Norway.

Eystein Skjerve (E)

Centre for Epidemiology and Biostatistics, Norwegian University of Life Sciences (NMBU), Oslo, Norway.

Jan Aaseth (J)

Innlandet Hospital Trust, Research Department, Brumunddal, Norway; Faculty of Health and Social Sciences, Inland Norway University of Applied Sciences, Elverum, Norway.

Jan L Lyche (JL)

Department of Food Safety and Infection Biology, Norwegian University of Life Sciences (NMBU), Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH